"Biogenic Amines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of naturally occurring amines derived by enzymatic decarboxylation of the natural amino acids. Many have powerful physiological effects (e.g., histamine, serotonin, epinephrine, tyramine). Those derived from aromatic amino acids, and also their synthetic analogs (e.g., amphetamine), are of use in pharmacology.
Descriptor ID |
D001679
|
MeSH Number(s) |
D02.092.211
|
Concept/Terms |
Biogenic Amines- Biogenic Amines
- Biogenic Amine
- Amine, Biogenic
- Amines, Biogenic
|
Below are MeSH descriptors whose meaning is more general than "Biogenic Amines".
Below are MeSH descriptors whose meaning is more specific than "Biogenic Amines".
This graph shows the total number of publications written about "Biogenic Amines" by people in this website by year, and whether "Biogenic Amines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1996 | 0 | 1 | 1 |
1999 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2005 | 1 | 1 | 2 |
2006 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biogenic Amines" by people in Profiles.
-
The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Mol Psychiatry. 2006 Nov; 11(11):984-91.
-
Pharmacotherapy of posttraumatic cognitive impairments. Behav Neurol. 2006; 17(1):25-42.
-
Neuronal signaling and the regulation of bone remodeling. Cell Mol Life Sci. 2005 Oct; 62(19-20):2339-49.
-
Indirect biochemical evidence that reserpine methiodide produces selective depletion of peripheral biogenic amines in rats. Pharmazie. 2005 Apr; 60(4):294-7.
-
Reserpine methonitrate, a novel quaternary analogue of reserpine augments urinary excretion of VMA and 5-HIAA without affecting HVA in rats. BMC Pharmacol. 2004 Nov 16; 4:30.
-
Non-amine-based dopamine transporter (reuptake) inhibitors retain properties of amine-based progenitors. Eur J Pharmacol. 2003 Oct 31; 479(1-3):41-51.
-
Possible role of neuropeptides in obsessive compulsive disorder. Psychoneuroendocrinology. 1999 Jan; 24(1):1-24.
-
Effect of tincture of Crataegus on the LDL-receptor activity of hepatic plasma membrane of rats fed an atherogenic diet. Atherosclerosis. 1996 Jun; 123(1-2):235-41.
-
Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls. Neuropsychopharmacology. 1995 Feb; 12(1):73-86.
-
Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls. Arch Gen Psychiatry. 1994 Oct; 51(10):782-92.